$1.735
-0.776 (-44.75%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BCAB por análisis de gráficos similares
Alphio's BCAB stock price prediction model matches the current Bioatla Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.74 (+0.52%). The 1-week path is $1.77 (+2.17%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Bioatla Inc?
BioAtla Inc is not a good buy right now due to its significant financial losses and poor stock performance. The current price is $1.74, which is a staggering 96.60% lower than its 1-year high of $71.50. Furthermore, the company has reported a negative net income of -$6,344,000 in Q1 2026, and a forward P/E ratio of 0 indicates uncertainty about future earnings. The recent hedge fund selling activity has increased by 760.39%, signaling a lack of confidence among institutional investors, which adds to the risk of holding this stock.
BCAB cerró en $1.74 el Friday, tras bajar -44.75%
Bioatla Inc (BCAB) last closed at $1.735, losing -44.75%. These facts feed the 1-day and 1-week BCAB price prediction above.
Factores de la previsión
Los factores de la previsión de Bioatla Inc (BCAB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BCAB, ordenadas por similitud.
Análisis de estacionalidad de BCAB
Historically the probability of a positive November return for BCAB is 48.72%. December offers the highest probability of a positive month at 48.84%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de BCAB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.40 | $0.43 | $0.51 | -75.50% |
| Dec 2026 | $0.32 | $0.39 | $0.43 | -77.60% |
En 2026, se proyecta que Bioatla Inc (BCAB) oscile entre $0.32 y $0.51.
Previsión mensual de Bioatla Inc para 2026
En Nov de 2026, se proyecta que Bioatla Inc promedie $0.43, con un mínimo de $0.40 y un máximo de $0.51.
En Dec de 2026, se proyecta que Bioatla Inc promedie $0.39, con un mínimo de $0.32 y un máximo de $0.43.
Artículos relacionados
- Equal-Weight vs Cap-Weighted S&P 500: RSP vs SPY After October's Rotation and Nvidia's CEO ShockEqual weight vs cap weighted S&P 500: how RSP and SPY differ, why October 2026's rotation was the widest since 2009, and how to blend both after Nvidia's shock.
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.